Clinical Trials
50 trialsN2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
SAFE-CAP
Yale University
The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer
Hebei Medical University Fourth Hospital
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Memorial Sloan Kettering Cancer Center
Immunobiome
University of Aarhus
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Memorial Sloan Kettering Cancer Center
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
FMT-TP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
Federal University of Minas Gerais
AIP2021
Fundació Sant Joan de Déu
XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
Guangzhou University of Traditional Chinese Medicine
PROCAR-BQ
Jules Bordet Institute
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
City of Hope Medical Center
ASF-BC
Uppsala University Hospital
L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients
Medical University of Gdansk
Loop
Philipps University Marburg
NET-PACS
Big Ten Cancer Research Consortium
Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs
University of Kentucky
SALFLADMET
Uppsala University Hospital
Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients
St. Jude Children's Research Hospital
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
University of Helsinki
The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute Fissure
Shiraz University of Medical Sciences
The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon
University of Aarhus
PRISME
Assistance Publique - Hôpitaux de Paris
Effect of the Use of Symbiotics in Patients With Colon Cancer
Federal University of Minas Gerais
Prevention and Treatment of Pyrrolitinib-associated Diarrhea
Tianjin Medical University Cancer Institute and Hospital
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
M.D. Anderson Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.
Case Comprehensive Cancer Center
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors
Catholic University of the Sacred Heart
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline
AHS Cancer Control Alberta
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Johns Hopkins University
CASAD for Severe Diarrhea in the Emergency Department
M.D. Anderson Cancer Center
DEKOR
Johann Wolfgang Goethe University Hospital
FOCCUS
Royal Marsden NHS Foundation Trust
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors
St. Jude Children's Research Hospital
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Alliance for Clinical Trials in Oncology
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
UNC Lineberger Comprehensive Cancer Center
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
H. Lee Moffitt Cancer Center and Research Institute
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
University of Southern California
Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy
Stanford University
Epidemiological Study of Colorectal Cancer in WuHan
Wuhan Pu-Ai Hospital
Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation
CHU de Quebec-Universite Laval
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
Roswell Park Cancer Institute
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
University of Alberta